Literature DB >> 15184460

Prospective comparison of the diagnostic potential of real-time PCR, double-sandwich enzyme-linked immunosorbent assay for galactomannan, and a (1-->3)-beta-D-glucan test in weekly screening for invasive aspergillosis in patients with hematological disorders.

Masahito Kawazu1, Yoshinobu Kanda, Yasuhito Nannya, Katsunori Aoki, Mineo Kurokawa, Shigeru Chiba, Toru Motokura, Hisamaru Hirai, Seishi Ogawa.   

Abstract

The establishment of an optimal noninvasive method for diagnosing invasive aspergillosis (IA) is needed to improve the management of this life-threatening infection in patients with hematological disorders, and a number of noninvasive tests for IA that target different fungal components, including galactomannan, (1-->3)-beta-d-glucan (BDG), and Aspergillus DNA, have been developed. In this study, we prospectively evaluated the diagnostic potential of three noninvasive tests for IA that were used in a weekly screening strategy: the double-sandwich enzyme-linked immunosorbent assay (ELISA) for galactomannan (Platelia Aspergillus), a real-time PCR assay for Aspergillus DNA (GeniQ-Asper), and an assay for BDG (beta-glucan Wako). We analyzed 149 consecutive treatment episodes in 96 patients with hematological disorders who were at high risk for IA and diagnosed 9 proven IA cases, 2 probable IA cases, and 13 possible invasive fugal infections. In a receiver-operating characteristic (ROC) analysis, the area under the ROC curve was greatest for ELISA, using two consecutive positive results (0.97; P = 0.036 for ELISA versus PCR, P = 0.055 for ELISA versus BDG). Based on the ROC curve, the cutoff for the ELISA could be reduced to an optical density index (O.D.I.) of 0.6. With the use of this cutoff for ELISA and cutoffs for PCR and BDG that give a comparable level of specificity, the sensitivity/specificity/positive predictive value/negative predictive value of the ELISA and the PCR and BDG tests were 1.00/0.93/0.55/1.00, 0.55/0.93/0.40/0.96, and 0.55/0.93/0.40/0.96, respectively. In conclusion, among these weekly screening tests for IA, the double-sandwich ELISA test was the most sensitive at predicting the diagnosis of IA in high-risk patients with hematological disorders, using a reduced cutoff of 0.6 O.D.I.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15184460      PMCID: PMC427860          DOI: 10.1128/JCM.42.6.2733-2741.2004

Source DB:  PubMed          Journal:  J Clin Microbiol        ISSN: 0095-1137            Impact factor:   5.948


  35 in total

1.  Screening for circulating galactomannan as a noninvasive diagnostic tool for invasive aspergillosis in prolonged neutropenic patients and stem cell transplantation recipients: a prospective validation.

Authors:  J Maertens; J Verhaegen; K Lagrou; J Van Eldere; M Boogaerts
Journal:  Blood       Date:  2001-03-15       Impact factor: 22.113

2.  Quantification of fungal DNA by using fluorescence resonance energy transfer and the light cycler system.

Authors:  J Loeffler; N Henke; H Hebart; D Schmidt; L Hagmeyer; U Schumacher; H Einsele
Journal:  J Clin Microbiol       Date:  2000-02       Impact factor: 5.948

3.  Early detection of aspergillus infection after allogeneic stem cell transplantation by polymerase chain reaction screening.

Authors:  H Hebart; J Löffler; C Meisner; F Serey; D Schmidt; A Böhme; H Martin; A Engel; D Bunje; W V Kern; U Schumacher; L Kanz; H Einsele
Journal:  J Infect Dis       Date:  2000-05-15       Impact factor: 5.226

4.  Comparison between PCR and detection of antigen in sera for diagnosis of pulmonary aspergillosis.

Authors:  S Kawamura; S Maesaki; T Noda; Y Hirakata; K Tomono; T Tashiro; S Kohno
Journal:  J Clin Microbiol       Date:  1999-01       Impact factor: 5.948

5.  Quantitative galactomannan detection is superior to PCR in diagnosing and monitoring invasive pulmonary aspergillosis in an experimental rat model.

Authors:  M J Becker; S de Marie; D Willemse; H A Verbrugh; I A Bakker-Woudenberg
Journal:  J Clin Microbiol       Date:  2000-04       Impact factor: 5.948

6.  Detection of Aspergillus species in blood and bronchoalveolar lavage samples from immunocompromised patients by means of 2-step polymerase chain reaction: clinical results.

Authors:  D Buchheidt; C Baust; H Skladny; J Ritter; T Suedhoff; M Baldus; W Seifarth; C Leib-Moesch; R Hehlmann
Journal:  Clin Infect Dis       Date:  2001-07-06       Impact factor: 9.079

7.  Aspergillus antigen in serum, urine and bronchoalveolar lavage specimens of neutropenic patients in relation to clinical outcome.

Authors:  J Salonen; O P Lehtonen; M R Teräsjärvi; J Nikoskelainen
Journal:  Scand J Infect Dis       Date:  2000

8.  Increasing volume and changing characteristics of invasive pulmonary aspergillosis on sequential thoracic computed tomography scans in patients with neutropenia.

Authors:  D Caillot; J F Couaillier; A Bernard; O Casasnovas; D W Denning; L Mannone; J Lopez; G Couillault; F Piard; O Vagner; H Guy
Journal:  J Clin Oncol       Date:  2001-01-01       Impact factor: 44.544

9.  Computed tomographic scan of the chest, latex agglutination test and plasma (1AE3)-beta-D-glucan assay in early diagnosis of invasive pulmonary aspergillosis: a prospective study of 215 patients.

Authors:  M Kami; Y Tanaka; Y Kanda; S Ogawa; T Masumoto; K Ohtomo; T Matsumura; T Saito; U Machida; T Kashima; H Hirai
Journal:  Haematologica       Date:  2000-07       Impact factor: 9.941

10.  Use of real-time PCR on blood samples for diagnosis of invasive aspergillosis.

Authors:  M Kami; T Fukui; S Ogawa; Y Kazuyama; U Machida; Y Tanaka; Y Kanda; T Kashima; Y Yamazaki; T Hamaki; S Mori; H Akiyama; Y Mutou; H Sakamaki; K Osumi; S Kimura; H Hirai
Journal:  Clin Infect Dis       Date:  2001-10-04       Impact factor: 9.079

View more
  55 in total

1.  Diagnostic potential of monoclonal antibodies developed against C-terminal polypeptide of P. falciparum Histidine Rich Protein2 (PfHRP2) in malaria infected patients from India.

Authors:  Reena Verma; Sara Chandy; N S Jayaprakash; Anand Manoharan; M A Vijayalakshmi; Krishnan Venkataraman
Journal:  Pathog Glob Health       Date:  2017-08-04       Impact factor: 2.894

Review 2.  Diagnostic accuracy of serum 1,3-β-D-glucan for pneumocystis jiroveci pneumonia, invasive candidiasis, and invasive aspergillosis: systematic review and meta-analysis.

Authors:  Akira Onishi; Daisuke Sugiyama; Yoshinori Kogata; Jun Saegusa; Takeshi Sugimoto; Seiji Kawano; Akio Morinobu; Kunihiro Nishimura; Shunichi Kumagai
Journal:  J Clin Microbiol       Date:  2011-11-09       Impact factor: 5.948

Review 3.  Polymerase chain reaction-based assays for the diagnosis of invasive fungal infections.

Authors:  Themistoklis K Kourkoumpetis; Beth Burgwyn Fuchs; Jeffrey J Coleman; Athanasios Desalermos; Eleftherios Mylonakis
Journal:  Clin Infect Dis       Date:  2012-02-23       Impact factor: 9.079

4.  A novel extraction method combining plasma with a whole-blood fraction shows excellent sensitivity and reproducibility for patients at high risk for invasive aspergillosis.

Authors:  Jan Springer; Hannes Schloßnagel; Werner Heinz; Thomas Doedt; Rainer Soeller; Hermann Einsele; Juergen Loeffler
Journal:  J Clin Microbiol       Date:  2012-05-16       Impact factor: 5.948

Review 5.  Aspergillus infections in transplant recipients.

Authors:  Nina Singh; David L Paterson
Journal:  Clin Microbiol Rev       Date:  2005-01       Impact factor: 26.132

6.  False positivity for Aspergillus antigenemia with amoxicillin-clavulonic acid.

Authors:  Gokhan Metan; Mine Durusu; Omrum Uzun
Journal:  J Clin Microbiol       Date:  2005-05       Impact factor: 5.948

7.  Use of real-time PCR to process the first galactomannan-positive serum sample in diagnosing invasive aspergillosis.

Authors:  Laurence Millon; Renaud Piarroux; Eric Deconinck; Claude-Eric Bulabois; Frédéric Grenouillet; Pierre Rohrlich; Jean-Marc Costa; Stéphane Bretagne
Journal:  J Clin Microbiol       Date:  2005-10       Impact factor: 5.948

8.  Development of a nested qualitative real-time PCR assay to detect Aspergillus species DNA in clinical specimens.

Authors:  Catriona Halliday; Qi Xuan Wu; Gregory James; Tania Sorrell
Journal:  J Clin Microbiol       Date:  2005-10       Impact factor: 5.948

9.  Nonculture diagnostic methods for invasive fungal infections.

Authors:  L Joseph Wheat
Journal:  Curr Infect Dis Rep       Date:  2007-11       Impact factor: 3.725

Review 10.  [Update: invasive fungal infections: Diagnosis and treatment in surgical intensive care medicine].

Authors:  C Lichtenstern; S Swoboda; M Hirschburger; E Domann; T Hoppe-Tichy; M Winkler; C Lass-Flörl; M A Weigand
Journal:  Anaesthesist       Date:  2010-01       Impact factor: 1.041

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.